Literature DB >> 25616271

Accessory hepatic vein recanalization for treatment of Budd-Chiari syndrome due to long-segment obstruction of the hepatic vein: initial clinical experience.

Yu Fei Fu1, Hao Xu, Ke Zhang, Qing Qiao Zhang, Ning Wei.   

Abstract

PURPOSE: We aimed to investigate the feasibility and effectiveness of accessory hepatic vein recanalization (balloon dilatation/stent insertion) for patients with Budd-Chiari syndrome (BCS) due to long-segment obstruction of the hepatic vein.
METHODS: From March 2010 to December 2013, 20 consecutive patients with BCS, due to long-segment obstruction of three hepatic veins, treated with accessory hepatic vein recanalization (11 males, 9 females; mean age, 33.4±10.9 years; range, 22-56 years) were included in this retrospective study. Data on technical success, clinical success, and follow-up were collected and analyzed.
RESULTS: Technical and clinical success was achieved in all patients. Each patient was managed with a single accessory hepatic vein recanalization procedure. No procedure-related complications occurred. The diameter of the accessory hepatic vein was 8.45±1.47 mm (6-11 mm) at the stem, and there were many collateral circulations between the hepatic vein and the accessory hepatic vein. The mean pressure of accessory hepatic vein decreased from 47.50±5.59 cm H2O before treatment to 28.80±3.47 cm H2O after treatment (P < 0.001). Abnormal levels of total bilirubin, albumin, aspartate aminotransferase, and alanine transaminase improved after the treatment. During the follow-up, three patients experienced restenosis or stenting of the accessory hepatic vein.
CONCLUSIONS: In BCS due to long-segment obstruction of the hepatic veins, it is important to confirm whether there is a compensatory accessory hepatic vein. For patients with a compensatory but obstructed accessory hepatic vein, recanalization is a simple, safe, and effective treatment option.

Entities:  

Mesh:

Year:  2015        PMID: 25616271      PMCID: PMC4463317          DOI: 10.5152/dir.2014.14128

Source DB:  PubMed          Journal:  Diagn Interv Radiol        ISSN: 1305-3825            Impact factor:   2.630


  15 in total

Review 1.  Is surgical portosystemic shunt the treatment of choice in Budd-Chiari syndrome?

Authors:  Ph Langlet; D Valla
Journal:  Acta Gastroenterol Belg       Date:  2002 Jul-Sep       Impact factor: 1.316

2.  Intrahepatic collateral recanalization in symptomatic Budd-Chiari syndrome: a single-center experience.

Authors:  Thomas Mammen; Shyamkumar Keshava; C E Eapen; Vinu Moses; N R S Surendra Babu; George Kurien; George Chandy
Journal:  J Vasc Interv Radiol       Date:  2010-05-26       Impact factor: 3.464

3.  Favourable medium term outcome following hepatic vein recanalisation and/or transjugular intrahepatic portosystemic shunt for Budd Chiari syndrome.

Authors:  C E Eapen; D Velissaris; M Heydtmann; B Gunson; S Olliff; E Elias
Journal:  Gut       Date:  2005-09-20       Impact factor: 23.059

4.  A study of the accessory hepatic vein to segments VI and VII with a morphological reconsideration of the human liver.

Authors:  Sichen Buhe; Takayoshi Miyaki; Toshiyuki Saito; Alimujiang Sawuti; Hayato Terayama; Munekazu Naito; Shuang-Qin Yi; Masahiro Itoh
Journal:  Surg Radiol Anat       Date:  2008-02-13       Impact factor: 1.246

5.  A simple formula to calculate the liver drainage volume of the accessory right hepatic vein using its diameter alone.

Authors:  Jun Hanaoka; Mitsuo Shimada; Hideaki Uchiyama; Toru Ikegami; Satoru Imura; Yuji Morine; Hirofumi Kanemura
Journal:  Surgery       Date:  2009-08       Impact factor: 3.982

6.  Percutaneous recanalization for Budd-Chiari syndrome: an 11-year retrospective study on patency and survival in 177 Chinese patients from a single center.

Authors:  Guohong Han; Xingshun Qi; Wei Zhang; Chuangye He; Zhanxin Yin; Jianhong Wang; Jielai Xia; Ke Xu; Wengang Guo; Jing Niu; Kaichun Wu; Daiming Fan
Journal:  Radiology       Date:  2012-11-09       Impact factor: 11.105

7.  Applicability of different endovascular methods for treatment of refractory Budd-Chiari syndrome.

Authors:  Yong Gao; Shiyuan Chen; Chaowen Yu
Journal:  Cell Biochem Biophys       Date:  2011-11       Impact factor: 2.194

8.  Living donor liver transplantation with extensive caval thrombectomy for acute-on-chronic Budd-Chiari syndrome.

Authors:  Akihiko Soyama; Susumu Eguchi; Katsuhiko Yanaga; Mitsuhisa Takatsuki; Masaaki Hidaka; Takashi Kanematsu
Journal:  Surg Today       Date:  2011-07-12       Impact factor: 2.549

9.  Treatment of Budd-Chiari syndrome with a focus on transjugular intrahepatic portosystemic shunt.

Authors:  Anders Bay Neumann; Stine Degn Andersen; Dennis Tønner Nielsen; Peter Holland-Fischer; Hendrik Vilstrup; Henning Grønbæk
Journal:  World J Hepatol       Date:  2013-01-27

10.  Long-term effect of stent placement in 115 patients with Budd-Chiari syndrome.

Authors:  Chun-Qing Zhang; Li-Na Fu; Lin Xu; Guo-Quan Zhang; Tao Jia; Ji-Yong Liu; Cheng-Yong Qin; Ju-Ren Zhu
Journal:  World J Gastroenterol       Date:  2003-11       Impact factor: 5.742

View more
  6 in total

1.  Endovascular treatment for hepatic vein-type Budd-Chiari syndrome: effectiveness and long-term outcome.

Authors:  Zhong-Ke Chen; Jing Fan; Chi Cao; Yu Li
Journal:  Radiol Med       Date:  2018-05-31       Impact factor: 3.469

2.  Single-access liver floss technique with antegrade hepatic vein access and recanalization in Budd-Chiari syndrome.

Authors:  John J Weaver; Ethan M Dobrow; Evelyn K Hsu; Eric J Monroe
Journal:  Diagn Interv Radiol       Date:  2018 Jan-Feb       Impact factor: 2.630

3.  Budd-Chiari syndrome: consensus guidance of the Asian Pacific Association for the study of the liver (APASL).

Authors:  Akash Shukla; Ananta Shreshtha; Amar Mukund; Chhagan Bihari; C E Eapen; Guohong Han; Hemant Deshmukh; Ian Homer Y Cua; Cosmas Rinaldi Adithya Lesmana; Mamun Al Meshtab; Masayoshi Kage; Roongruedee Chaiteeraki; Sombat Treeprasertsuk; Suprabhat Giri; Sundeep Punamiya; Valerie Paradis; Xingshun Qi; Yasuhiko Sugawara; Zaigham Abbas; Shiv Kumar Sarin
Journal:  Hepatol Int       Date:  2021-07-08       Impact factor: 6.047

4.  Hepatic vein variations in 500 patients: surgical and radiological significance.

Authors:  Binit Sureka; Neelmani Sharma; Pushpinder Singh Khera; Pawan Kumar Garg; Taruna Yadav
Journal:  Br J Radiol       Date:  2019-07-11       Impact factor: 3.039

5.  Excellent long-term outcomes of endovascular treatment in budd-chiari syndrome with hepatic veins involvement: A STROBE-compliant article.

Authors:  Yonghua Bi; Hongmei Chen; Pengxu Ding; Pengli Zhou; Xinwei Han; Jianzhuang Ren
Journal:  Medicine (Baltimore)       Date:  2018-10       Impact factor: 1.817

6.  Evaluation of outcome from endovascular therapy for Budd-Chiari syndrome: a systematic review and meta-analysis.

Authors:  Gauri Mukhiya; Xueliang Zhou; Xinwei Han; Dechao Jiao; Gaurab Pokhrel; Yahua Li; Sita Pokhrel
Journal:  Sci Rep       Date:  2022-09-28       Impact factor: 4.996

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.